Pharma Journalist 8769 posts 0 comments

miRagen Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, today announced that the U.S. Food and…
Read More...

Espero Pharmaceuticals, Inc., a privately held, commercial-stage cardiovascular pharmaceutical company, and Armetheon, Inc., a privately held, late-clinical stage pharmaceutical company…
Read More...

Healthcare companies in Europe will have access to more responsive, flexible printing services for their packaging needs thanks to Amcor’s continued investments in printing technology…
Read More...

Hilleman Laboratories, a joint-venture partnership between MSD and Wellcome Trust, signed a Memorandum of Understanding (MoU) with National Institute of Cholera and Enteric Diseases…
Read More...

Clinical-stage immuno-oncology firm Agenus is reorganizing its business and operations to straighten its focus on clinical development of its two checkpoint inhibitor antibodies and…
Read More...

Vanda Pharmaceuticals Inc. announced that it has entered into a license agreement with UC San Francisco (UCSF), under which Vanda will acquire an exclusive worldwide license from UCSF…
Read More...

Sonoma Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced…
Read More...

Mylan N.V., today announced the successful acquisition of the global rights to the Cold-EEZE brand cold remedy line from ProPhase Labs, Inc. The transaction provides Mylan all assets…
Read More...

Mylan announced the successful acquisition of the global rights to the Cold-EEZE brand cold remedy line from ProPhase Labs, Inc. The transaction provides Mylan all assets and rights…
Read More...

Sonoma Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced…
Read More...